论文部分内容阅读
目的:探讨分析剖宫产术后瘢痕子宫中期妊娠的临床引产方法。方法:选取我院2012年6月-2013年6月间收治的60例剖宫产术后瘢痕子宫中期妊娠引产患者,根据引产方法的不同,分为观察组和对照组,每组患者各30例。观察组给予米索前列醇引产,对照组给予利凡诺羊膜腔穿刺术引产。观察比较两组引产情况。结果:在用药至宫缩开始时间,用药至分娩开始时间,产时至产后2小时出血量方面比较,观察组明显优于对照组,P<0.05,有统计学意义;在引产成功率,分娩期并发症方面比较,P>0.05,具有可比性;在药物不良反应方面比较,对照组明显优于观察组,P<0.05,有统计学意义。结论:米索前列醇引产和利凡诺羊膜腔穿刺术引产均为安全有效的剖宫产术后瘢痕子宫中期妊娠临床引产方法,临床应根据孕妇的要求来选择引产方法。
Objective: To explore the method of clinical induction of scar pregnancy uterus after cesarean section. Methods: From June 2012 to June 2013 in our hospital, 60 cases of cesarean scar after uterine incision induction of labor in the second trimester of pregnancy, according to different methods of induction of labor, divided into observation group and control group, each group of 30 example. The observation group was given misoprostol induction of labor, and the control group was given rivanol amniocentesis. Observation and comparison of labor induction in both groups. Results: Compared with the control group, the observation group was significantly better than the control group in medication start time to start of delivery, birth time to delivery and 2 hours after delivery, P <0.05, statistically significant; in the induction of labor success rate, childbirth Complications of phase, P> 0.05, comparable; adverse drug reactions in the control group was significantly better than the observation group, P <0.05, with statistical significance. Conclusion: Both misoprostol induction and rivanol amniocentesis are safe and effective clinical induction of labor after mid-term pregnancy of cesarean scar. The clinical method should be based on the requirements of pregnant women.